<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Migraine-associated stroke: risk factors, diagnosis, and prevention
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Migraine-associated stroke: risk factors, diagnosis, and prevention
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Migraine-associated stroke: risk factors, diagnosis, and prevention
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Muhammad Ramzan, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sandhya Mehla, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jerry W Swanson, MD, MHPE
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Scott E Kasner, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard P Goddeau, Jr, DO, FAHA
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen Eckler, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 11, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Migraine is a common headache disorder characterized by symptoms that typically occur over several hours to a few days. Migraine-associated stroke (also known as migrainous infarction or migraine-induced stroke) is an uncommon complication of migraine identified by ischemic stroke on neuroimaging that corresponds to prolonged aura symptoms in a patient with migraine. This topic will discuss migraine-associated stroke and stroke prevention for patients with migraine.
        </p>
        <p>
         The general approach to the diagnosis and evaluation of migraine is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults"
         </a>
         .)
        </p>
        <p>
         Other risk factors and preventive treatment for ischemic stroke are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1120.html" rel="external">
          "Overview of secondary prevention of ischemic stroke"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H279694796">
         <span class="h1">
          MIGRAINE-ASSOCIATED ISCHEMIC STROKE
         </span>
        </p>
        <p class="headingAnchor" id="H2454133726">
         <span class="h2">
          Epidemiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Migraine and ischemic stroke are both common conditions. The epidemiology of the intersection of migraine and stroke can be examined by the prevalence of migraine in stroke patients and the prevalence of stroke in patients with migraine. The epidemiology of the risk of stroke due to migraine may be assessed by the incidence of migrainous infarction.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Migraine prevalence
         </strong>
         — Data on the prevalence of migraine in stroke patients vary in different retrospective studies. A small case-control study of 145 patients in France reported that the relative prevalence of migraine among patients with ischemic stroke was double that of controls (60 versus 30 percent) [
         <a href="#rid1">
          1
         </a>
         ]. In a European World Health Organization (WHO) collaborative study, the prevalence of migraine in patients with all types of stroke compared with controls was 25 versus 13 percent [
         <a href="#rid2">
          2
         </a>
         ]. However, this study has been criticized on several grounds, including the high proportion of migraine with aura patients compared with those without aura and the high incidence of migrainous stroke (between 20 to 40 percent) among the study participants, a finding that does not concur with clinical experience [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Among younger adults with a history of stroke, migraine prevalence rates range between 27 and 34 percent. The Collaborative Group for the Study of Stroke in Young Women found that the prevalence of migraine in females with stroke, other hospitalized patients, and controls was 34, 33, and 24 percent, respectively [
         <a href="#rid4">
          4
         </a>
         ]. In a case-control study of 1668 adults &lt;45 years old with cryptogenic stroke, the prevalence of migraine was 27 percent, compared with 17 percent for matched controls [
         <a href="#rid5">
          5
         </a>
         ]. The applicability of these data to older patients is uncertain. Younger patients have higher baseline prevalence of migraine and lower burden of stroke risks than older patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Stroke prevalence
         </strong>
         – The prevalence of stroke in patients with migraine is low but varies according to cerebrovascular risk factors. In a retrospective cohort of more than 800,000 young adults (age 18 to 44 years) with migraine, the prevalence of ischemic stroke was 1.3 percent [
         <a href="#rid6">
          6
         </a>
         ]. The risk of ischemic stroke was assessed in a population-based cohort study of more than 220,000 patients with migraine from Denmark [
         <a href="#rid7">
          7
         </a>
         ]. The absolute risk of ischemic stroke was modestly higher for both females and males with migraine than matched controls (0.3 and 0.5 percent, respectively). A similar modest increased risk of myocardial infarction was also reported. In a meta-analysis of 11 cohort studies that included more than two million patients with migraine, the pooled risk of ischemic stroke was also found to be higher for patients with migraine than those without (relative risk 1.64, 95% CI 1.2-2.2) [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidence of migrainous infarction
         </strong>
         — The reported incidence of stroke due to migraine (migrainous infarction) ranges from 0.8 to 3.4 per 100,000 per year [
         <a href="#rid9">
          9,10
         </a>
         ]. However, the true incidence is unknown due to reporting bias and varied criteria used to identify patients with migraine. In a Taiwanese case-control study involving nearly 240,000 patients, the risk of ischemic stroke over a median of 3.6-year interval was higher for patients with a history of migraine than those without (adjusted hazard ratio [aHR] 1.24, 95% CI, 1.1-1.4) [
         <a href="#rid11">
          11
         </a>
         ]. A meta-analysis of nine observational studies found the pooled relative risk (RR) for ischemic stroke among subjects with any type of migraine was 1.73 (95% CI 1.31-2.29) [
         <a href="#rid12">
          12
         </a>
         ]. The strength of this meta-analysis is limited mainly by the case-control nature of many of the studies, with their inherent susceptibility to recall bias. In addition, the included studies were heterogeneous with regard to subject characteristics and cardiovascular disease definitions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Case series and stroke registries have reported migrainous infarction accounts for an estimated 0.2 to 0.8 percent of all ischemic strokes [
         <a href="#rid9">
          9,13-16
         </a>
         ]. However, migraine-induced stroke accounted for 13.7 percent of infarcts in young adults in a study that used a strict definition of migrainous infarction [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The epidemiology of ischemic stroke and of migraine are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/1089.html" rel="external">
          "Stroke: Etiology, classification, and epidemiology", section on 'Epidemiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Epidemiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4133959907">
         <span class="h2">
          Modifiers of risk
         </span>
         <span class="headingEndMark">
          —
         </span>
         Among patients with migraine, the risk of ischemic stroke is elevated in those with specific factors including migraine aura, female sex, smoking, and exposure to hormonal contraception [
         <a href="#rid12">
          12
         </a>
         ]. Similar clinical factors have been reported in other studies [
         <a href="#rid11">
          11,17
         </a>
         ]. In a study of nearly 120,000 patients in Taiwan that compared patients with migraine and a propensity score-matched comparison cohort, migraine was associated with an increased risk of ischemic stroke (aHR 1.2, 95% CI 1.1-1.4) with the highest risk among females aged ≤45 years who had migraine with aura (aHR 4.6, 95% CI 2.5-8.6) [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         While migraine may confer a risk for stroke, the presence of active migraine headaches may attenuate this risk and indicate a healthy vascular system. In an analysis of patients from the Women’s Health Study stratifying patients by present versus past history of migraine, females age ≥45 years old with an elevated risk of future cardiovascular disease were likelier to have a history of migraine than those with a low risk of future cardiovascular disease but less likely to have an active history of migraine (odds ratio [OR] 0.64, 95% CI 0.5-0.8) [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1069161777">
         <span class="h3">
          Migraine aura
         </span>
         <span class="headingEndMark">
          —
         </span>
         The increased risk of stroke in patients with migraine appears to be driven largely from subjects who have migraine with aura [
         <a href="#rid12">
          12,19-21
         </a>
         ]. In one meta-analysis of 16 cohort studies involving more than 1.1 million patients, migraine was associated with an elevated risk of stroke (aHR 1.4, 95% CI 1.3-1.6) [
         <a href="#rid21">
          21
         </a>
         ]. When stratified by migraine subtype, the risk was elevated for patients with migraine with aura (aHR 1.6, 95% CI 1.3-1.9) but not those with migraine without aura (aHR 1.1, 95% CI 0.9-1.3). In an analysis of more than 27,000 female health professionals from the Women’s Health Study cohort, the adjusted incidence rate of major cardiovascular events was 3.36 per 1000 person-years (95% CI 2.72-3.99) for those with migraine with aura and 2.11 per 1000 person-years (95% CI 1.98-2.24) for those with migraine without aura or no migraine history [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
         In addition, migraine appears to be associated with an elevated perioperative stroke risk, driven largely migraine with aura. In a prospective hospital registry of nearly 125,000 surgical patients, the risk of perioperative ischemic stroke was elevated for patients with and without aura but higher for patients with a history of migraine with aura (adjusted OR [aOR] 2.61, 95% CI 1.6-4.3) than those with migraine without aura (aOR 1.6, 95% CI 1.3-2.1) [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1270506825">
         <span class="h3">
          Female sex
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is evidence that females with migraine are at an increased risk of ischemic stroke [
         <a href="#rid12">
          12,22,24
         </a>
         ], but the absolute increase in risk of stroke remains low in the absence of other stroke risk factors [
         <a href="#rid19">
          19,25,26
         </a>
         ]. In the Women’s Health Study, patients with migraine experienced four additional ischemic stroke events per 10,000 females each year [
         <a href="#rid25">
          25
         </a>
         ]. However, on a population level, the small increase in absolute risk remains important as the prevalence of females with migraine with aura is over 4 percent [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Impact of age
         </strong>
         – The baseline thrombotic stroke incidence appears to be 11 to 21 per 100,000 females age 15 to 49 years old in population-based studies but varies with age, with an estimated incidence of 3 per 100,000 for females 15 to 19 years old up to 64 per 100,000 for females 45 to 49 years old [
         <a href="#rid28">
          28,29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Impact of aura
         </strong>
         – Meta-analyses have reported the stroke risk to be 2.0 to 2.5 times greater among females with migraine with aura compared with no aura [
         <a href="#rid12">
          12,19
         </a>
         ]. There is some evidence that increased frequency of migraine with aura is related to increased burden of ischemic stroke risk factors [
         <a href="#rid30">
          30
         </a>
         ]. (See
         <a class="local">
          'Migraine aura'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Impact of cardiovascular risk factors
         </strong>
         – Stroke risk among females is further increased with hypertension, diabetes, and ischemic heart disease [
         <a href="#rid12">
          12,29,31,32
         </a>
         ]. (See
         <a class="local">
          'Modifiers of risk'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
         Discussions of stroke risk related to estrogen-containing contraception are discussed below. (See
         <a class="local">
          'Estrogen-containing contraception'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2957052074">
         <span class="h3">
          Estrogen-containing contraception
         </span>
         <span class="headingEndMark">
          —
         </span>
         The use of estrogen-containing contraception is associated with an increased relative risk of ischemic stroke in patients with migraine [
         <a href="#rid33">
          33
         </a>
         ]. The absolute risk of stroke remains low for most patients who use estrogen-containing contraception, excluding those with migraine with aura.
        </p>
        <p>
         Studies have estimated a 2- to 16-fold relative risk elevation in this population [
         <a href="#rid33">
          33-35
         </a>
         ]. However, significant limitations of studies of contraception, migraine, and stroke include that they generally combine a wide range of estrogen doses (including doses no longer in typical use), differing progestin components (which may also impact stroke risk), multiple routes of administration (oral pill, vaginal ring, transdermal patch), and different types of migraine (without versus with aura), which other reports have identified as important factors related to stroke risk [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Estrogen dose
         </strong>
         – Increasing estrogen dose appears to increase stroke risk. In a large, population-based cohort study in Denmark, the RR of ischemic stroke increased with increasing doses of ethinyl estradiol (20 mcg dose: adjusted RR 0.88-1.53; 30 to 40 mcg doses: adjusted RR 1.40-2.20) [
         <a href="#rid28">
          28
         </a>
         ]. Compared with those with neither migraine nor combination hormonal contraceptive use, the OR of ischemic stroke was highest among those with migraine with aura using combination hormonal therapy (OR 6.1, 95% CI 3.1-12.1).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Aura
         </strong>
         – The presence of aura appears to increase the risk of future stroke among patients taking estrogen-containing contraception. In a systematic review of 15 studies, the risk of stroke for individuals using estrogen-containing contraceptives was higher for patients with aura compared with without (with aura: ORs of 6.1, 95% CI 3.1-12.1 versus without aura: OR 1.8, 95% CI 1.1-2.9) [
         <a href="#rid34">
          34
         </a>
         ]. The authors concluded that the review demonstrated "a lack of good quality studies assessing risk of stroke associated with low-dose estrogen use in women with migraine. Further study in this area is needed."
        </p>
        <p>
        </p>
        <p>
         These and other impacts of estrogen-containing contraceptives are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7399.html" rel="external">
          "Combined estrogen-progestin contraception: Side effects and health concerns"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4034674041">
         <span class="h3">
          Other factors
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Smoking
         </strong>
         – Smoking is a risk factor for stroke and also modifies the risk of stroke among patients with migraine. In a meta-analysis of studies assessing the association between migraine and cardiovascular risk factors that evaluated the role of smoking, the risk of ischemic stroke was significantly elevated among patients with migraine who smoke (pooled RR 9, 95% CI 4.2-19.3) [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Age
         </strong>
         – The risk of stroke among patients with migraine appears to be higher for patients age &lt;45 years compared with older patients [
         <a href="#rid12">
          12
         </a>
         ]. This observation may reflect the higher prevalence of migraine among younger patients and/or the increased burden of other vascular risk factors in older patients. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H249246020">
         <span class="h2">
          Mechanisms
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathophysiology underlying migraine as a risk factor or cause for stroke is not clear. Prolonged or severe changes in cerebral blood flow have been frequently postulated as the cause of migrainous infarction. However, this assumption has been challenged by the limited supportive data and competing nonvascular causes to migraine that may cause or contribute to the risk of stroke. Multiple cerebral, vascular, hematologic, and cardiac mechanisms have been suggested, including the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cerebral and neuronal factors
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prolongation of cortical spreading depression (CSD) and aura [
         <a href="#rid20">
          20
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neuronal glutamatergic hyperexcitability resulting in enhanced susceptibility to ischemic depolarizations [
         <a href="#rid37">
          37,38
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dysregulated activity of serotonergic raphe cells causing excitotoxicity [
         <a href="#rid39">
          39
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vascular factors
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Vasospasm and changes in cerebral blood flow [
         <a href="#rid3">
          3,40-44
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Release of prothrombotic factors or vasoactive peptides [
         <a href="#rid45">
          45-50
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Endothelial dysfunction [
         <a href="#rid38">
          38,51
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prothrombotic factors
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased platelet aggregability [
         <a href="#rid52">
          52-54
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Elevated von Willebrand factor [
         <a href="#rid49">
          49
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Higher prevalence of hypercoagulable states [
         <a href="#rid55">
          55
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prothrombotic genetic polymorphisms (eg, the methylenetetrahydrofolate reductase
         <em>
          C677T
         </em>
         variant) [
         <a href="#rid56">
          56
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/6837.html" rel="external">
          "Overview of homocysteine", section on 'Disease associations'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiac factors
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Atrial fibrillation attributed to the autonomic dysfunction associated with migraine [
         <a href="#rid57">
          57,58
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Myocardial infarction associated with migraine leading to cardioembolism [
         <a href="#rid26">
          26,59-62
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         None of the postulated mechanisms have been confirmed as a pathophysiological explanation linking stroke and migraine. However, posterior circulation border zone infarcts in migraine have been most frequently attributed to a combination of low flow (hypoperfusion) and local thromboembolism [
         <a href="#rid63">
          63,64
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Shared risk factors
         </strong>
         – In addition, migraine has been associated with other known or putative risk factors for stroke, including:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patent foramen ovale (PFO) [
         <a href="#rid65">
          65
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Right-to-left cardiac shunt'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1092.html" rel="external">
          "Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cervical artery dissection [
         <a href="#rid66">
          66
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/14082.html" rel="external">
          "Cerebral and cervical artery dissection: Clinical features and diagnosis", section on 'Associated conditions and risk factors'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [
         <a href="#rid67">
          67
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/1091.html" rel="external">
          "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)", section on 'Migraine with aura'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms (MELAS) [
         <a href="#rid68">
          68
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/5151.html" rel="external">
          "Mitochondrial myopathies: Clinical features and diagnosis", section on 'MELAS'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Antiphospholipid antibodies and lupus [
         <a href="#rid69">
          69-72
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/4667.html" rel="external">
          "Clinical manifestations of antiphospholipid syndrome", section on 'Neurologic involvement'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Livedo reticularis and Sneddon syndrome [
         <a href="#rid73">
          73-76
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sickle cell disease [
         <a href="#rid77">
          77
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/7119.html" rel="external">
          "Overview of the clinical manifestations of sickle cell disease", section on 'Neurologic complications'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cardiovascular disease including myocardial infarction [
         <a href="#rid26">
          26,59-62
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         The pathophysiology of migraine is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Pathophysiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3009086796">
         <span class="h2">
          Clinical and imaging findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical features of migraine-associated stroke vary according to the criteria used. Data on clinical features of patients who have had acute migrainous infarction and a complete stroke evaluation are limited. The largest study with modern neuroimaging is a case series of 11 patients with migrainous infarction according to strict criteria who were identified from a stroke database of 8137 patients [
         <a href="#rid78">
          78
         </a>
         ]. All patients reported symptoms at onset similar to previous migraine aura without new or atypical symptoms. However, the previously transient aura symptoms persisted. On diffusion-weighted brain magnetic resonance imaging (MRI) sequences, 4 of the 11 patients had multiple foci of acute infarction, mainly in the posterior circulation, while four had a single area of acute infarction in the posterior circulation territory, and three had isolated infarcts in the middle cerebral artery territory  (
         <a class="graphic graphic_diagnosticimage graphicRef57203" href="/z/d/graphic/57203.html" rel="external">
          image 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H2838874702">
         <span class="h2">
          Evaluation and diagnosis of migrainous stroke
         </span>
         <span class="headingEndMark">
          —
         </span>
         It can be difficult to determine migraine as the cause of stroke; there are no diagnostic findings specific to migraine-induced stroke and experts vary in defining migraine-associated stroke [
         <a href="#rid3">
          3,40,79-83
         </a>
         ]. Patients who develop a stroke during a migraine headache should have a comprehensive evaluation to exclude other possible causes.
        </p>
        <p>
         The diagnosis and evaluation of ischemic stroke are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/1123.html" rel="external">
          "Initial evaluation and management of transient ischemic attack and minor ischemic stroke"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1788391963">
         <span class="h3">
          Diagnostic criteria
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Migrainous infarction
         </strong>
         — The International Classification of Headache Disorders, 3
         <sup>
          rd
         </sup>
         edition (ICHD-3) defines migrainous infarction by the following features [
         <a href="#rid83">
          83
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (A) A migraine attack fulfilling criteria B and C
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (B) Occurring in a patient with migraine with aura and typical of previous attacks except that one or more aura symptoms persists for &gt;60 minutes
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (C) Neuroimaging demonstrates ischemic infarction in a relevant area
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (D) Not better accounted for by another diagnosis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Migrainous infarction also may be called migraine-induced stroke [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Migraine-related stroke
         </strong>
         — Some experts have used the term migraine-related stroke for patients whose symptoms do not fulfill all diagnostic criteria for migrainous infarction and also to allow inclusion of patients who have migraine without aura [
         <a href="#rid40">
          40
         </a>
         ]. Since the 1990s, when migraine was thought to have only vascular pathophysiology, several reports have noted the occurrence of migrainous infarction associated with attacks of migraine without aura [
         <a href="#rid79">
          79-81
         </a>
         ]. However, most studies have found no association of migraine without aura and ischemic stroke [
         <a href="#rid83">
          83,84
         </a>
         ]. (See
         <a class="local">
          'Migraine aura'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other experts use migraine-related stroke for cases when additional stroke mechanisms coexist with migraine [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2556039042">
         <span class="h2">
          Differential diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both cerebrovascular events and migraine attacks can present as acute transient neurologic events with similar symptoms  (
         <a class="graphic graphic_table graphicRef111740" href="/z/d/graphic/111740.html" rel="external">
          table 1
         </a>
         ). In addition, acute neurologic symptoms that are persistent may also be caused by either migraine or stroke.
        </p>
        <p class="headingAnchor" id="H786622365">
         <span class="h3">
          Forms of migraine with aura
         </span>
         <span class="headingEndMark">
          —
         </span>
         Migraine with aura occurs in about 15 to 20 percent or more of patients with migraine and may mimic stroke [
         <a href="#rid85">
          85
         </a>
         ]. Neuroimaging may be performed for patients with atypical migraine features to exclude stroke. (See
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Diagnostic testing'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Typical aura
         </strong>
         – Typical migraine aura symptoms develop gradually over 5 to 20 minutes and last less than one hour per symptom; the most common types involve homonymous visual disturbances. Other common types of migraine aura may manifest as sensory, motor, brainstem, or language disturbances. There is usually little clinical difficulty recognizing these aura symptoms as manifestations of migraine when the auras are brief and precede headaches. In addition, migraine aura is typically characterized by positive symptoms (eg, presence of bright lights or visual aberrations) while stroke symptoms typically involve loss of function or negative symptoms (eg, vision loss). (See
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Migraine aura'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other forms of migraine
         </strong>
         – Some forms of migraine present with motor or brainstem symptoms that may mimic transient ischemic attack (TIA) or acute stroke. These include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sporadic and familial hemiplegic migraine (see
         <a class="medical medical_review" href="/z/d/html/14112.html" rel="external">
          "Hemiplegic migraine"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Migraine with brainstem aura (see
         <a class="medical medical_review" href="/z/d/html/3352.html" rel="external">
          "Migraine with brainstem aura"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Retinal or ocular migraine (see
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Retinal migraine'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Hemiplegic and brainstem auras may also be prolonged, requiring neuroimaging evaluation to distinguish from acute stroke.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Migraine aura without headache
         </strong>
         – Migraine aura that occurs without headache may be difficult to distinguish from stroke symptoms. This form of migraine was previously known as acephalgic migraine and migraine with acute-onset aura. These symptoms are more common in patients over age 50 years and may also be called late-life migraine accompaniments [
         <a href="#rid86">
          86
         </a>
         ]. Imaging may be required to exclude stroke as cause to these symptoms.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Persistent aura without infarction
         </strong>
         – Prolonged symptoms may last for the entire headache, for several days or weeks, or in some cases leave a permanent neurologic deficit. Many such patients have neuroimaging evidence of acute stroke, indicating migrainous infarction. However, some patients have persistent aura without infarction if the aura lasts one week or longer with no evidence of infarction. (See
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Complications of migraine'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The general approach to the differential diagnosis of migraine is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3073845659">
         <span class="h3">
          Other causes of stroke presenting with headache
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some patients with ischemic or hemorrhagic cerebrovascular conditions may present neurologic symptoms and headache or with isolated headache without associated focal neurologic impairment, such as weakness, numbness, aphasia, or visual dysfunction [
         <a href="#rid3">
          3
         </a>
         ]. Specific stroke symptoms vary according to the brain regions impacted and some small cerebrovascular lesions may not produce neurologic deficits. Headache may occur due to activation of nociceptors in vascular walls from acute thrombosis or those in dural membranes from local mass effect of bleeding or edema. Cerebrovascular conditions that may commonly present with isolated headache include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intracranial hemorrhage
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Subarachnoid hemorrhage
         </strong>
         – Aneurysmal subarachnoid hemorrhage (SAH) frequently presents with acute onset (thunderclap) severe headache [
         <a href="#rid87">
          87
         </a>
         ]. Other patients may present with a prodrome or less severe headaches, frequently called "sentinel headaches" up to several days prior to overt SAH [
         <a href="#rid88">
          88
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1130.html" rel="external">
          "Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis", section on 'Clinical presentation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Subdural and epidural hematomas
         </strong>
         – Acute intracranial bleeding in the potential spaces adjacent to the nociceptor-containing dural membranes can present with acute or chronic headaches. Epidural hematomas may present with headache due to bleeding between the dura and inner table of the skull, but additional neurologic deficits from mass effect on the underlying brain tissue are common, such as hemiparesis or impaired consciousness. Similarly, subdural hematomas (SDH), due to bleeding between the dura and arachnoid membranes, can present with headache with or without other neurologic deficits. Patients with chronic SDH are likelier to present with nonfocal symptoms such as isolated headache, but symptoms may be progressive if the bleeding expands. (See
         <a class="medical medical_review" href="/z/d/html/1107.html" rel="external">
          "Intracranial epidural hematoma in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1105.html" rel="external">
          "Subdural hematoma in adults: Etiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Intracerebral hemorrhage
         </strong>
         – For patients with intracerebral hemorrhage (ICH), headache may occur acutely at stroke onset or may occur within hours of onset as the hematoma gradually expands and begins to compress pain sensitive intracranial structures such as larger arteries and the meninges. Large volume intracerebral hemorrhages may present with headache that is typically associated with nausea and/or vomiting and a decreased level of consciousness due to mass effect of the bleeding and brain compression. (See
         <a class="medical medical_review" href="/z/d/html/1133.html" rel="external">
          "Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis", section on 'Clinical presentation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ischemic stroke
         </strong>
         – Headache can occasionally occur with TIA or ischemic stroke due to acute arterial thromboembolism. For patients with ischemic stroke of large vessel origin, headache may occur prior to, during, or after stroke onset [
         <a href="#rid89">
          89
         </a>
         ]. In one prospective study of 284 patients with acute ischemic stroke, concomitant headache during the early phase of stroke was reported by 38 percent [
         <a href="#rid90">
          90
         </a>
         ]. Although the cause is often unclear, several plausible mechanisms have been postulated, including vascular dilation as a homeostatic response to ischemia and direct arterial irritation by thrombus, embolism, or dissection [
         <a href="#rid91">
          91
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1134.html" rel="external">
          "Clinical diagnosis of stroke subtypes", section on 'Associated symptoms'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Headache may be common with specific ischemic stroke presentations and causes, including the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cervical internal carotid artery dissection
         </strong>
         – Cervical internal carotid artery dissection may occasionally present with isolated headache or as a migraine mimic with visual scintillating scotomata [
         <a href="#rid92">
          92,93
         </a>
         ]. One study of 161 patients found that nearly 70 percent of cervical carotid and vertebral dissections were associated with headache, and headache was the initial symptom in 33 to 47 percent [
         <a href="#rid94">
          94
         </a>
         ]. Another study found that 19 of 21 patients with angiographically documented carotid dissection had ipsilateral head pain in one or more regions such as the orbit, frontal region, and side of the head [
         <a href="#rid95">
          95
         </a>
         ]. The head pain was typically acute and severe, and neck pain occurred as well in 12 patients. Approximately three quarters of the 21 patients had ischemic events related to the dissection, with the headache preceding the ischemic symptoms in about half.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         The relationship of dissection with headache is further complicated because approximately half of patients with cervical artery dissection also have a prior history of migraine. (See
         <a class="local">
          'Mechanisms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Insular cortex infarction
         </strong>
         – Ischemic stroke involving the insula may present with headache [
         <a href="#rid96">
          96
         </a>
         ]. One study using MRI lesion mapping found that infarctions in the insular cortex were significantly associated with headache, perhaps related to the role of this region in pain processing [
         <a href="#rid97">
          97
         </a>
         ]. Headache is uncommon in subcortical small vessel stroke syndromes. (See
         <a class="medical medical_review" href="/z/d/html/1134.html" rel="external">
          "Clinical diagnosis of stroke subtypes"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1083.html" rel="external">
          "Overview of the evaluation of stroke"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Posterior circulation infarction
         </strong>
         – Multiple observational studies have reported an association between headache and acute ischemic stroke involving the posterior arterial circulation [
         <a href="#rid96">
          96,98-100
         </a>
         ]. A meta-analysis of observational studies of adults with ischemic stroke found that the prevalence of headache in patients with posterior circulation stroke was nearly twice that of patients with anterior circulation stroke (OR 1.9, 95% CI 1.4-2.6) [
         <a href="#rid101">
          101
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Migraine has also been associated with the presence of asymptomatic stroke-like lesions in the posterior circulation on brain MRI in patients without a clinical history of stroke. (See
         <a class="local">
          'Subclinical brain lesions'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Malignant hemispheric infarction
         </strong>
         – Headache due to cerebral edema may develop in patients with large ischemic strokes but is typically associated with additional neurologic deficits. (See
         <a class="medical medical_review" href="/z/d/html/1096.html" rel="external">
          "Malignant cerebral hemispheric infarction with swelling and risk of herniation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cerebral venous thrombosis
         </strong>
         – Headache is the most common clinical feature of cerebral venous thrombosis (CVT) being present in nearly 90 percent of patients [
         <a href="#rid102">
          102
         </a>
         ]. Headache characteristics in CVT may be focal or diffuse and can mimic migraine but are frequently gradually progressive. (See
         <a class="medical medical_review" href="/z/d/html/1103.html" rel="external">
          "Cerebral venous thrombosis: Etiology, clinical features, and diagnosis", section on 'Headache'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Reversible cerebral vasoconstriction syndromes
         </strong>
         – Reversible cerebral vasoconstriction syndrome (RCVS) is a group of conditions characterized by reversible narrowing of the cerebral arteries. The clinical presentation of RCVS is usually dramatic with sudden, severe "thunderclap" headaches that simulate aneurysmal SAH; however, in patients with RCVS, thunderclap headaches often recur over a span of one to four weeks. The etiology of RCVS is unknown, though the reversible nature of the vasoconstriction suggests an abnormality in the control of cerebrovascular tone.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Recurrence of an episode of RCVS is rare, but some patients develop chronic headaches after RCVS, which are usually migrainous in nature.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         RCVS is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/14075.html" rel="external">
          "Reversible cerebral vasoconstriction syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Others
         </strong>
         – Headache may also be a presenting feature of other cerebrovascular conditions. These conditions share a common pathophysiology involving failure of cerebral blood flow autoregulation or endothelial dysfunction [
         <a href="#rid103">
          103
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Reversible posterior leukoencephalopathy syndrome [
         <a href="#rid104">
          104
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/4835.html" rel="external">
          "Reversible posterior leukoencephalopathy syndrome"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypertensive encephalopathy [
         <a href="#rid103">
          103,105
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/3833.html" rel="external">
          "Moderate to severe hypertensive retinopathy and hypertensive encephalopathy in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cerebral hyperperfusion syndrome [
         <a href="#rid106">
          106
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/15843.html" rel="external">
          "Complications of carotid endarterectomy", section on 'Hyperperfusion syndrome'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Stroke-like migraine attacks after radiation therapy (SMART) [
         <a href="#rid107">
          107
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/91670.html" rel="external">
          "Delayed complications of cranial irradiation", section on 'Migraine-like headache (SMART) syndrome'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cerebral arteriovenous malformation (AVM) [
         <a href="#rid108">
          108,109
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/1087.html" rel="external">
          "Brain arteriovenous malformations", section on 'Clinical presentation'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Moyamoya disease and syndrome [
         <a href="#rid110">
          110
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/1131.html" rel="external">
          "Moyamoya disease and moyamoya syndrome: Etiology, clinical features, and diagnosis", section on 'Other manifestations'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Vasculitis involving the central nervous system (both primary and systemic) [
         <a href="#rid111">
          111-114
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/8230.html" rel="external">
          "Primary angiitis of the central nervous system in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8226.html" rel="external">
          "Overview of and approach to the vasculitides in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         CADASIL [
         <a href="#rid115">
          115,116
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/1091.html" rel="external">
          "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)", section on 'Migraine with aura'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Some of these conditions may present with headaches that have migrainous features. Patients with cerebral AVMs may present with migraine-like attacks that lateralize to the same cerebral hemisphere [
         <a href="#rid108">
          108,109,117
         </a>
         ]. Migraine-like headaches are a frequent and early manifestation of both SMART syndrome and CADASIL and may be the sole symptom in some patients.
        </p>
        <p>
        </p>
        <p>
         Other conditions in the differential diagnosis of stroke are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1137.html" rel="external">
          "Differential diagnosis of transient ischemic attack and acute stroke"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1273204001">
         <span class="h3">
          Migraine coincidental with stroke
         </span>
         <span class="headingEndMark">
          —
         </span>
         Migraine or other headache may occur coincidentally with stroke since both are common conditions. With advancing age, the prevalence of migraine decreases, while that of stroke increases. In addition, stroke risk factors such as hypertension, diabetes, and heart disease are more common in older age groups.
        </p>
        <p>
         Migraine and stroke may occur together as presenting features of or covariables for other conditions such as antiphospholipid antibody syndrome and CADASIL. (See
         <a class="local">
          'Mechanisms'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H3483629374">
         <span class="h2">
          Management
         </span>
         <span class="headingEndMark">
          —
         </span>
         The general approach to the acute stroke treatment of patients with migraine is similar to other patients without migraine. Acute stroke management is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/1126.html" rel="external">
          "Initial assessment and management of acute stroke", section on 'Ischemic stroke management'
         </a>
         .)
        </p>
        <p>
         Treatment aimed at primary or secondary stroke prevention in patients with migraine or nonspecific headache is not well studied, but an approach combining stroke risk factor control with migraine prophylaxis seems most reasonable. Patients with additional stroke risk factors such as hypertension, tobacco use, or high-estrogen-containing oral contraception should be informed about the increased stroke risk, and efforts should be taken to minimize risks.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Education
         </strong>
         – Patients with migraine should be taught to recognize the early warning signs of stroke to prevent confusion between migraine aura and TIA  (
         <a class="graphic graphic_table graphicRef111740" href="/z/d/graphic/111740.html" rel="external">
          table 1
         </a>
         ) and to seek appropriate intervention. Similarly, clinicians should be aware of the potentially increased risk of stroke in the migraine population and should not dismiss focal symptoms in their evaluation of these patients. (See
         <a class="medical medical_review" href="/z/d/html/1137.html" rel="external">
          "Differential diagnosis of transient ischemic attack and acute stroke", section on 'Distinguishing transient attacks'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Managing medications
         </strong>
         – Specific medication management strategies for patients with stroke and migraine are discussed below. (See
         <a class="local">
          'Managing medications that impact stroke risk'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         General preventive therapy for stroke and treatment of migraine are discussed in greater detail separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7573.html" rel="external">
          "Overview of primary prevention of cardiovascular disease"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1120.html" rel="external">
          "Overview of secondary prevention of ischemic stroke"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3347.html" rel="external">
          "Acute treatment of migraine in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3345.html" rel="external">
          "Preventive treatment of episodic migraine in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1311289362">
         <span class="h1">
          OTHER MIGRAINE-ASSOCIATED CEREBROVASCULAR MANIFESTATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H2554028873">
         <span class="h2">
          Intracerebral hemorrhage
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most studies have reported on the association between migraine and ischemic stroke. However, migraine has been identified as a possible risk factor for other cerebrovascular conditions, including intracerebral hemorrhage [
         <a href="#rid26">
          26
         </a>
         ]. The relationship of migraine with intracerebral hemorrhage is supported by a meta-analysis of eight studies (four case-control and four cohort), which found that the overall pooled effect estimate of hemorrhagic stroke was 1.48 (95% CI 1.16-1.88) for subjects with any migraine [
         <a href="#rid118">
          118
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1624967700">
         <span class="h2">
          Subclinical brain lesions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several prospective population-based studies have found an association between migraine with aura and silent infarct-like lesions on brain MRI [
         <a href="#rid14">
          14,63,119-121
         </a>
         ]. However, the etiology, nature, and clinical significance of the MRI lesions reported in these studies remains unclear [
         <a href="#rid121">
          121,122
         </a>
         ].
        </p>
        <p>
         Two patterns of brain lesions have been associated with migraine with aura:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infarct-like lesions in the posterior circulation territory
         </strong>
         – In a population-based study of 4689 subjects from Iceland, subjects were evaluated at a mean age of 51 years and then reevaluated at a mean age of 76 years by interview and brain MRI. Those subjects who reported migraine with aura at the initial evaluation had an increased risk of infarct-like lesions 25 years later (adjusted odds ratio [aOR] 1.4, 95% CI 1.1-1.8) [
         <a href="#rid120">
          120
         </a>
         ]. This result was driven mainly by an increased risk of cerebellar infarct-like lesions in the subgroup of females who had migraine with aura (odds ratio [OR] 1.9, 95% CI 1.4-2.6). Migraine with (but not without) aura was also associated with an increased risk for subclinical posterior circulation territory infarct-like lesions in a cross-sectional study of Dutch adults aged 30 to 60 years [
         <a href="#rid119">
          119
         </a>
         ]. Most lesions were in the cerebellum. In another study report, patients with migraine had a significantly increased prevalence of small infratentorial hyperintense lesions, most located in the mid-pons [
         <a href="#rid123">
          123
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          White matter lesions
         </strong>
         - A 2013 systematic review and meta-analysis of four clinic-based case-control studies found that white matter lesions were more common in subjects with migraine compared with controls [
         <a href="#rid121">
          121
         </a>
         ]. The association was significant for migraine with aura (OR 1.68, 95% CI 1.07-2.65) but not for migraine without aura (OR 1.34, 95% CI 0.96-1.87). By contrast, a subsequent population-based study found that severe white matter disease was associated with migraine without aura (OR 1.87, 95% CI 1.04-3.37) but not with migraine with aura (OR 0.55, 95% CI 0.17-1.83) [
         <a href="#rid124">
          124
         </a>
         ]. In this study, a history of migraine was not associated with white matter lesion progression over time [
         <a href="#rid124">
          124
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h1">
          MANAGING MEDICATIONS THAT IMPACT STROKE RISK
         </span>
        </p>
        <p class="headingAnchor" id="H1113243221">
         <span class="h2">
          Indications for antithrombotic therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The indications for antithrombotic therapy are not impacted by migraine, either with or without aura.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Primary prevention
         </strong>
         – Primary prevention of stroke with
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         or other antiplatelet therapy is
         <strong>
          not
         </strong>
         warranted for patients with migraine with or without aura in the absence of cardiovascular risk factors. (See
         <a class="medical medical_review" href="/z/d/html/16291.html" rel="external">
          "Aspirin in the primary prevention of cardiovascular disease and cancer", section on 'Assessing benefits and risks'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Secondary prevention
         </strong>
         – Secondary stroke prevention with antiplatelet or anticoagulant medications is warranted for patients with and without migraine who have a history of transient ischemic attack (TIA) or stroke. (See
         <a class="medical medical_review" href="/z/d/html/1120.html" rel="external">
          "Overview of secondary prevention of ischemic stroke", section on 'Antithrombotic therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1501233147">
         <span class="h2">
          Use of estrogen-containing therapies
         </span>
         <span class="headingEndMark">
          —
         </span>
         While estrogen-containing therapies are associated with an increased risk of venous thromboembolism and ischemic stroke, these medications can be used safely in many patients with migraine depending on the migraine characteristics (no aura), estrogen indication (contraception or therapy for menopause symptoms), dose, delivery (oral, transdermal), and relative benefits compared with risks. However, estrogen-containing medications are typically avoided in patients with migraine with aura who have a history of stroke or are at elevated risk for cardiovascular disease, including stroke. The cardiovascular impact of estrogen-containing contraceptives is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/7399.html" rel="external">
          "Combined estrogen-progestin contraception: Side effects and health concerns", section on 'Cardiovascular effects'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h3">
          Hormonal contraception
         </span>
         <span class="headingEndMark">
          —
         </span>
         The decision to start or continue estrogen-containing contraceptive therapy in patients with migraine involves shared decision making after discussing individual risks and benefits of therapy and alternative options. Estrogen-containing contraceptives include oral pills, transdermal patches, and vaginal rings  (
         <a class="graphic graphic_figure graphicRef57795" href="/z/d/graphic/57795.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5459.html" rel="external">
          "Contraception: Counseling and selection"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Without aura
         </strong>
         – Patients experiencing migraine without aura who are otherwise candidates for estrogen-containing contraception can safely use estrogen-containing contraceptives, including oral pills, transdermal patches, and vaginal rings [
         <a href="#rid125">
          125-127
         </a>
         ]. If contraceptive pills are selected, formulations containing ≤35 mcg of ethinyl estradiol, or the equivalent, are preferred  (
         <a class="graphic graphic_table graphicRef69223" href="/z/d/graphic/69223.html" rel="external">
          table 2
         </a>
         ). Patients who elect estrogen-containing contraceptives should be younger than 35 years if they are smokers and do not have other cardiovascular, thromboembolism, or stroke risk factors [
         <a href="#rid125">
          125-127
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Detailed discussions, including supporting data, on candidates and risks related to estrogen-containing contraception are presented separately.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7398.html" rel="external">
          "Combined estrogen-progestin oral contraceptives: Patient selection, counseling, and use", section on 'Candidates'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7399.html" rel="external">
          "Combined estrogen-progestin contraception: Side effects and health concerns"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          With aura
         </strong>
         – Individuals with aura are generally not candidates for estrogen-containing contraceptives [
         <a href="#rid31">
          31,125-128
         </a>
         ]. However, high-quality studies specific to low-dose estrogen products are lacking [
         <a href="#rid34">
          34
         </a>
         ]. Therefore, the use of estrogen-containing contraception in patients with aura should be individualized. For those with a clear indication for estrogen-containing contraceptives, such as endometriosis or those who desire this method after a clear discussion of the risks, their use may be reasonable.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Presentation of the data regarding candidates for estrogen-containing contraception, contraindications, and risks associated with use are discussed separately.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7398.html" rel="external">
          "Combined estrogen-progestin oral contraceptives: Patient selection, counseling, and use"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7399.html" rel="external">
          "Combined estrogen-progestin contraception: Side effects and health concerns"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Consideration of other medical conditions
         </strong>
         – We and other experts use comprehensive tables of medical conditions and personal characteristics from the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) to counsel patients regarding safe use of the various hormonal methods of contraception [
         <a href="#rid125">
          125,126
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7398.html" rel="external">
          "Combined estrogen-progestin oral contraceptives: Patient selection, counseling, and use", section on 'Candidates'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2126034027">
         <span class="h3">
          Menopausal hormone therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Concerns have been raised that estrogen-containing hormone therapy for symptoms of menopause may increase stroke risk. However, available data conflict, in part because of variables such as patient age and medical comorbidities as well as estrogen dose and route of administration. These issues are reviewed in detail in related content. (See
         <a class="medical medical_review" href="/z/d/html/7409.html" rel="external">
          "Menopausal hormone therapy and cardiovascular risk"
         </a>
         .)
        </p>
        <p>
         The safety of menopausal hormone therapy, either estrogen alone or estrogen plus progestin, in patients with migraine varies by migraine type and the patient’s thromboembolic risk.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients who should avoid estrogen
         </strong>
         – We
         <strong>
          avoid
         </strong>
         estrogen-containing menopausal hormone therapy for patients with migraine with aura and a history of stroke or those who are otherwise at high risk (eg, &gt;10 percent 10-year risk) for cardiovascular disease including stroke (
         <a class="calc calc_professional" href="/z/d/html/107063.html" rel="external">
          calculator 1
         </a>
         ). For these patients, we use nonhormonal options that are not associated with an elevated risk of thromboembolic complications. (See
         <a class="medical medical_review" href="/z/d/html/7390.html" rel="external">
          "Menopausal hot flashes", section on 'Nonhormonal pharmacotherapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Estrogen use acceptable
         </strong>
         – Menopausal estrogen therapy is acceptable for patients with migraine with or without aura and otherwise at low risk of cardiovascular disease (ie, ≤10 percent 10-year risk). The rationale is that the estrogen therapy for menopausal symptoms is not a supraphysiologic dose (as it is with estrogen-containing contraceptives).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7427.html" rel="external">
          "Menopausal hormone therapy: Benefits and risks"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7450.html" rel="external">
          "Treatment of menopausal symptoms with hormone therapy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Additional discussion on use of estrogen therapy in peri- and postmenopausal patients with migraine is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5441.html" rel="external">
          "Estrogen-associated migraine headache, including menstrual migraine", section on 'Peri- and postmenopause'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1116876958">
         <span class="h2">
          Medications to avoid
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some medications are
         <strong>
          avoided
         </strong>
         in those who have migraine with aura and a history of stroke, TIA, or cardiovascular disease due the risk of cerebral ischemia. These include vasoconstrictive medications:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Triptans
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9416" href="/z/d/drug information/9416.html" rel="external">
          Ergotamine
         </a>
         derivatives
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serotonin antagonists (eg,
         <a class="drug drug_general" data-topicid="10091" href="/z/d/drug information/10091.html" rel="external">
          pizotifen
         </a>
         and methysergide)
        </p>
        <p>
        </p>
        <p>
         In a case-control study of patients prescribed
         <a class="drug drug_general" data-topicid="9416" href="/z/d/drug information/9416.html" rel="external">
          ergotamine
         </a>
         or triptans, 188 patients hospitalized with ischemic events were age and sex-matched with 689 controls. Ergotamine overuse was a risk factor for ischemic complications (odds ratio [OR] 2.55, 95% CI 1.22-5.36); but triptan overuse was not [
         <a href="#rid129">
          129
         </a>
         ]. However, cases of cardiac arrest, cerebral infarcts, and spinal cord infarcts have been reported in the setting of triptan use [
         <a href="#rid130">
          130-134
         </a>
         ].
        </p>
        <p>
         We also
         <strong>
          avoid
         </strong>
         long-term use of nonsteroidal antiinflammatory drugs (NSAIDs) in older patients and in patients with other uncontrolled risk factors for stroke due to the elevated risk of thrombotic cardiovascular events [
         <a href="#rid135">
          135
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7968.html" rel="external">
          "NSAIDs: Adverse cardiovascular effects", section on 'NSAIDs and cardiovascular events'
         </a>
         .)
        </p>
        <p>
         We suggest that beta blockers should
         <strong>
          not
         </strong>
         be used as initial therapy for migraine prophylaxis in patients over age 60 years and in patients who smoke. Compared with other antihypertensive drugs in the primary treatment of hypertension, beta blockers may be associated with a higher rate of stroke and other cardiovascular events. (See
         <a class="medical medical_review" href="/z/d/html/3869.html" rel="external">
          "Choice of drug therapy in primary (essential) hypertension"
         </a>
         .)
        </p>
        <p>
         The safety of calcitonin gene-related peptide antagonists has not been established for patients with a migraine with aura and a history of or uncontrolled risk factors for stroke [
         <a href="#rid136">
          136,137
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H814990094">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/105370.html" rel="external">
          "Society guideline links: Stroke in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15328.html" rel="external">
          "Patient education: Stroke (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/16238.html" rel="external">
          "Patient education: Medicines after an ischemic stroke (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/112403.html" rel="external">
          "Patient education: Migraines in adults (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/734.html" rel="external">
          "Patient education: Migraines in adults (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/726.html" rel="external">
          "Patient education: Stroke symptoms and diagnosis (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/723.html" rel="external">
          "Patient education: Ischemic stroke treatment (Beyond the Basics)"
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H29">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Migraine-associated ischemic stroke
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Epidemiology
         </strong>
         – The reported incidence of stroke due to migraine (migrainous stroke) ranges from 0.8 to 3.4 per 100,000 per year.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Clinical factors associated with an elevated risk of stroke in patients with migraine include (see
         <a class="local">
          'Modifiers of risk'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Patients with migraine with aura
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Female patients
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Patients who smoke
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Patients who take estrogen-containing contraception
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Patients age &lt;45 years
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Clinical and imaging findings
         </strong>
         – Clinical symptoms of migraine-associated stroke are typically similar to previous migraine aura without new or atypical symptoms. However, the previously transient aura symptoms persist for longer duration. Infarction is frequently located in the posterior circulation and may be multifocal. (See
         <a class="local">
          'Clinical and imaging findings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Diagnosis
         </strong>
         – Migrainous infarction occurs in a patient with migraine with aura that is typical of previous attacks except that one or more aura symptoms persists for &gt;60 minutes. Neuroimaging demonstrates ischemic infarction in a relevant area. (See
         <a class="local">
          'Diagnostic criteria'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – Both cerebrovascular events and migraine attacks can present as acute transient neurologic events with similar symptoms  (
         <a class="graphic graphic_table graphicRef111740" href="/z/d/graphic/111740.html" rel="external">
          table 1
         </a>
         ). In addition, acute neurologic symptoms that are persistent may also be caused by either migraine or stroke.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Management
         </strong>
         – The general approach to the acute stroke treatment of patients with migraine is similar to other patients without migraine. Treatment aimed at primary or secondary stroke prevention in patients with migraine involves combining stroke risk factor control with migraine prophylaxis. Patients should be taught to recognize the early warning signs of stroke to prevent confusion between migraine aura and transient ischemic attack (TIA)  (
         <a class="graphic graphic_table graphicRef111740" href="/z/d/graphic/111740.html" rel="external">
          table 1
         </a>
         ) and to seek appropriate intervention. (See
         <a class="local">
          'Management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Migraine and other stroke subtypes
         </strong>
         – Migraine has been identified as a possible risk factor for other cerebrovascular conditions, including intracerebral hemorrhage and silent infarct-like lesions on brain MRI. (See
         <a class="local">
          'Other migraine-associated cerebrovascular manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Managing medications that impact stroke risk
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Antithrombotic therapy
         </strong>
         – Primary prevention of stroke with
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         is
         <strong>
          not
         </strong>
         warranted for patients with migraine with or without aura in the absence of cardiovascular risk factors. Secondary stroke prevention with antiplatelet or anticoagulant medications is warranted for patients with and without migraine who have a history of TIA or stroke. (See
         <a class="local">
          'Indications for antithrombotic therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Estrogen-containing therapies
         </strong>
         – While estrogen-containing therapies are associated with an increased risk of thromboembolism, these medications can be used safely in select patients with migraine depending on the migraine characteristics (no aura), estrogen dose, and relative benefits compared with risks. (See
         <a class="local">
          'Use of estrogen-containing therapies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Hormonal contraception
         </strong>
         – We suggest that patients with migraine with aura
         <strong>
          avoid
         </strong>
         estrogen-containing contraceptives (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). We give similar guidance to patients with other forms of migraine and an additional risk factor for stroke.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         Patients who are nonsmokers &lt;35 years, without aura, and have no additional thromboembolic risk factors may consider estrogen-containing contraceptives. If oral contraceptives are selected, we prefer formulations containing 35 mcg or less of estrogen. (See
         <a class="local">
          'Hormonal contraception'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Menopausal hormone therapy
         </strong>
         – We suggest that patients with migraine with aura and a history of stroke or at high risk for future cardiovascular disease (
         <a class="calc calc_professional" href="/z/d/html/107063.html" rel="external">
          calculator 1
         </a>
         )
         <strong>
          avoid
         </strong>
         estrogen-containing menopausal hormone therapy (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Menopausal estrogen therapy is acceptable for patients with migraine with or without aura who are at low risk of cardiovascular disease, including stroke (ie, ≤10 percent 10-year risk). (See
         <a class="local">
          'Menopausal hormone therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Migraine medications to avoid
         </strong>
         – We
         <strong>
          avoid
         </strong>
         triptans,
         <a class="drug drug_general" data-topicid="9416" href="/z/d/drug information/9416.html" rel="external">
          ergotamine
         </a>
         derivatives, serotonin antagonists, and long-term use of nonsteroidal antiinflammatory drugs (NSAIDs) for patients with migraine with aura and a history of stroke or cardiovascular disease. We do not use beta blockers for patients over age 60 years and those who smoke. (See
         <a class="local">
          'Medications to avoid'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1736738625">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Marc Fisher, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Tzourio C, Tehindrazanarivelo A, Iglésias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995; 310:830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999; 318:13.
          </a>
         </li>
         <li class="breakAll">
          Diener HC, Welch KMA, Mohr JP. Migraine and stroke. In: Stroke: pathophysiology, diagnosis, and management, Mohr JP, Choi DW, Grotta JC, et al. (Eds), Churchill Livingstone, Philadelphia 2004. p.629.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oral contraceptives and stroke in young women. Associated risk factors. JAMA 1975; 231:718.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazzoleni V, Grassi M, Lodigiani C, et al. Migraine and Cryptogenic Ischemic Stroke. Ann Neurol 2021; 89:627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuybu O, Amireh A, Davis D, et al. Prevalence of ischemic stroke and atrial fibrillation in young patients with migraine national inpatient sample analysis. J Stroke Cerebrovasc Dis 2020; 29:104972.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hvitfeldt Fuglsang C, Pedersen L, Schmidt M, et al. Migraine and risk of premature myocardial infarction and stroke among men and women: A Danish population-based cohort study. PLoS Med 2023; 20:e1004238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hu X, Zhou Y, Zhao H, Peng C. Migraine and the risk of stroke: an updated meta-analysis of prospective cohort studies. Neurol Sci 2017; 38:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sochurkova D, Moreau T, Lemesle M, et al. Migraine history and migraine-induced stroke in the Dijon stroke registry. Neuroepidemiology 1999; 18:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henrich JB, Sandercock PA, Warlow CP, Jones LN. Stroke and migraine in the Oxfordshire Community Stroke Project. J Neurol 1986; 233:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peng KP, Chen YT, Fuh JL, et al. Migraine and incidence of ischemic stroke: A nationwide population-based study. Cephalalgia 2017; 37:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schürks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009; 339:b3914.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arboix A, Massons J, García-Eroles L, et al. Migrainous cerebral infarction in the Sagrat Cor Hospital of Barcelona stroke registry. Cephalalgia 2003; 23:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee MJ, Lee C, Chung CS. The Migraine-Stroke Connection. J Stroke 2016; 18:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milhaud D, Bogousslavsky J, van Melle G, Liot P. Ischemic stroke and active migraine. Neurology 2001; 57:1805.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Linetsky E, Leker RR, Ben-Hur T. Headache characteristics in patients after migrainous stroke. Neurology 2001; 57:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Øie LR, Kurth T, Gulati S, Dodick DW. Migraine and risk of stroke. J Neurol Neurosurg Psychiatry 2020; 91:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ibrahimi K, Rist PM, Carpenet C, et al. Vascular Risk Score and Associations With Past, Current, or Future Migraine in Women: Cohort Study. Neurology 2022; 99:e1694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spector JT, Kahn SR, Jones MR, et al. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 2010; 123:612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical implications. Lancet Neurol 2012; 11:92.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahmoud AN, Mentias A, Elgendy AY, et al. Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open 2018; 8:e020498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurth T, Rist PM, Ridker PM, et al. Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women. JAMA 2020; 323:2281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Timm FP, Houle TT, Grabitz SD, et al. Migraine and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study. BMJ 2017; 356:i6635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rist PM, Buring JE, Kase CS, et al. Migraine and functional outcome from ischemic cerebral events in women. Circulation 2010; 122:2551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurth T, Diener HC. Migraine and stroke: perspectives for stroke physicians. Stroke 2012; 43:3421.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adelborg K, Szépligeti SK, Holland-Bill L, et al. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study. BMJ 2018; 360:k96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Merikangas KR. Contributions of epidemiology to our understanding of migraine. Headache 2013; 53:230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lidegaard Ø, Løkkegaard E, Jensen A, et al. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012; 366:2257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Champaloux SW, Tepper NK, Monsour M, et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol 2017; 216:489.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurth T, Schürks M, Logroscino G, Buring JE. Migraine frequency and risk of cardiovascular disease in women. Neurology 2009; 73:581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacClellan LR, Giles W, Cole J, et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 2007; 38:2438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ng CYH, Tan BYQ, Teo YN, et al. Myocardial infarction, stroke and cardiovascular mortality among migraine patients: a systematic review and meta-analysis. J Neurol 2022; 269:2346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tepper NK, Whiteman MK, Zapata LB, et al. Safety of hormonal contraceptives among women with migraine: A systematic review. Contraception 2016; 94:630.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheikh HU, Pavlovic J, Loder E, Burch R. Risk of Stroke Associated With Use of Estrogen Containing Contraceptives in Women With Migraine: A Systematic Review. Headache 2018; 58:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA 2000; 284:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas DJ. Migraine and ischaemic stroke. BMJ 2005; 330:54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eikermann-Haerter K, Lee JH, Yuzawa I, et al. Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Circulation 2012; 125:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mawet J, Kurth T, Ayata C. Migraine and stroke: in search of shared mechanisms. Cephalalgia 2015; 35:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eggers AE. New neural theory of migraine. Med Hypotheses 2001; 56:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Welch KM, Levine SR. Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol 1990; 47:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henrich JB. The association between migraine and cerebral vascular events: an analytical review. J Chronic Dis 1987; 40:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woods RP, Iacoboni M, Mazziotta JC. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994; 331:1689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olesen J, Friberg L, Olsen TS, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993; 116 ( Pt 1):187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rothrock JF, Walicke P, Swenson MR, et al. Migrainous stroke. Arch Neurol 1988; 45:63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferrari MD, Odink J, Tapparelli C, et al. Serotonin metabolism in migraine. Neurology 1989; 39:1239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gallai V, Sarchielli P, Firenze C, et al. Endothelin 1 in migraine and tension-type headache. Acta Neurol Scand 1994; 89:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soriani S, Borgna-Pignatti C, Trabetti E, et al. Frequency of factor V Leiden in juvenile migraine with aura. Headache 1998; 38:779.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hering-Hanit R, Friedman Z, Schlesinger I, Ellis M. Evidence for activation of the coagulation system in migraine with aura. Cephalalgia 2001; 21:137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tietjen GE, Al-Qasmi MM, Athanas K, et al. Increased von Willebrand factor in migraine. Neurology 2001; 57:334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology 2005; 64:S9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tietjen GE. Migraine as a systemic vasculopathy. Cephalalgia 2009; 29:987.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Andrea G, Hasselmark L, Alecci M, et al. Platelet secretion from dense and alpha-granules in vitro in migraine with or without aura. J Neurol Neurosurg Psychiatry 1994; 57:557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalendovsky Z, Austin JH. "Complicated migraine" its association with increased platelet aggregability and abnormal plasma coagulation factors. Headache 1975; 15:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeller JA, Frahm K, Baron R, et al. Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J Neurol Neurosurg Psychiatry 2004; 75:984.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martínez-Sánchez P, Martínez-Martínez M, Fuentes B, et al. Migraine and hypercoagulable states in ischemic stroke. Cephalalgia 2011; 31:1609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scher AI, Terwindt GM, Verschuren WM, et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 2006; 59:372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shechter A, Stewart WF, Silberstein SD, Lipton RB. Migraine and autonomic nervous system function: a population-based, case-control study. Neurology 2002; 58:422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aygun D, Altintop L, Doganay Z, et al. Electrocardiographic changes during migraine attacks. Headache 2003; 43:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rose KM, Wong TY, Carson AP, et al. Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. Neurology 2007; 68:1694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007; 167:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bigal ME, Kurth T, Santanello N, et al. Migraine and cardiovascular disease: a population-based study. Neurology 2010; 74:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurth T, Winter AC, Eliassen AH, et al. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ 2016; 353:i2610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 2005; 128:2068.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998; 55:1475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tietjen GE, Collins SA. Hypercoagulability and Migraine. Headache 2018; 58:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rist PM, Diener HC, Kurth T, Schürks M. Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia 2011; 31:886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chabriat H, Joutel A, Dichgans M, et al. Cadasil. Lancet Neurol 2009; 8:643.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vollono C, Primiano G, Della Marca G, et al. Migraine in mitochondrial disorders: Prevalence and characteristics. Cephalalgia 2018; 38:1093.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silvestrini M, Matteis M, Troisi E, et al. Migrainous stroke and the antiphospholipid antibodies. Eur Neurol 1994; 34:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levine SR, Joseph R, D'Andrea G, Welch KM. Migraine and the lupus anticoagulant. Case reports and review of the literature. Cephalalgia 1987; 7:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cuadrado MJ, Sanna G. Headache and systemic lupus erythematosus. Lupus 2003; 12:943.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Straube A, Padovan CS, Förderreuther S, Wick M. [Antinuclear and anticardiolipin antibodies in primary headache syndromes]. Schmerz 1998; 12:342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tietjen GE, Gottwald L, Al-Qasmi MM, et al. Migraine is associated with livedo reticularis: a prospective study. Headache 2002; 42:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tietjen GE, Al-Qasmi MM, Shukairy MS. Livedo reticularis and migraine: a marker for stroke risk? Headache 2002; 42:352.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rebollo M, Val JF, Garijo F, et al. Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome). Clinical, radiological and pathological features in eight cases. Brain 1983; 106 ( Pt 4):965.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martinelli A, Martinelli P, Ippoliti M, et al. Sneddon syndrome presenting with hemicranic attacks: a case report. Acta Neurol Scand 1991; 83:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silva GS, Vicari P, Figueiredo MS, et al. Migraine-mimicking headache and sickle cell disease: a transcranial Doppler study. Cephalalgia 2006; 26:678.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolf ME, Szabo K, Griebe M, et al. Clinical and MRI characteristics of acute migrainous infarction. Neurology 2011; 76:1911.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Narbone MC, Leggiadro N, La Spina P, et al. Migraine stroke: a possible complication of both migraine with and without aura. Headache 1996; 36:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rothrock J, North J, Madden K, et al. Migraine and migrainous stroke: risk factors and prognosis. Neurology 1993; 43:2473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ebinger F, Boor R, Gawehn J, Reitter B. Ischemic stroke and migraine in childhood: coincidence or causal relation? J Child Neurol 1999; 14:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dayno JM, Silberstein SD. Migraine-related stroke versus migraine-induced stroke. Headache 1997; 37:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martinez-Majander N, Artto V, Ylikotila P, et al. Association between Migraine and Cryptogenic Ischemic Stroke in Young Adults. Ann Neurol 2021; 89:242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Terrin A, Toldo G, Ermani M, et al. When migraine mimics stroke: A systematic review. Cephalalgia 2018; 38:2068.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci 1980; 7:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorelick PB, Hier DB, Caplan LR, Langenberg P. Headache in acute cerebrovascular disease. Neurology 1986; 36:1445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polmear A. Sentinel headaches in aneurysmal subarachnoid haemorrhage: what is the true incidence? A systematic review. Cephalalgia 2003; 23:935.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitsias P, Ramadan NM. Headache in ischemic cerebrovascular disease. Part I: Clinical features. Cephalalgia 1992; 12:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Os HJ, Mulder IA, van der Schaaf IC, et al. Role of atherosclerosis, clot extent, and penumbra volume in headache during ischemic stroke. Neurology 2016; 87:1124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitsias P, Ramadan NM. Headache in ischemic cerebrovascular disease. Part II: Mechanisms and predictive value. Cephalalgia 1992; 12:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramadan NM, Tietjen GE, Levine SR, Welch KM. Scintillating scotomata associated with internal carotid artery dissection: report of three cases. Neurology 1991; 41:1084.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silverman IE, Wityk RJ. Transient migraine-like symptoms with internal carotid artery dissection. Clin Neurol Neurosurg 1998; 100:116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silbert PL, Mokri B, Schievink WI. Headache and neck pain in spontaneous internal carotid and vertebral artery dissections. Neurology 1995; 45:1517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fisher CM. The headache and pain of spontaneous carotid dissection. Headache 1982; 22:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seifert CL, Schönbach EM, Zimmer C, et al. Association of clinical headache features with stroke location: An MRI voxel-based symptom lesion mapping study. Cephalalgia 2018; 38:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seifert CL, Schönbach EM, Magon S, et al. Headache in acute ischaemic stroke: a lesion mapping study. Brain 2016; 139:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Altiparmak T, Nazliel B, Caglayan HB, et al. Headache features of cerebellar ischemic strokes: Clinical and radiological-experiences of a single center. J Clin Neurosci 2021; 88:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferro JM, Melo TP, Oliveira V, et al. A multivariate study of headache associated with ischemic stroke. Headache 1995; 35:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nardi K, Parnetti L, Pieri ML, et al. Association between migraine and headache attributed to stroke: a case-control study. Headache 2008; 48:1468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harriott AM, Karakaya F, Ayata C. Headache after ischemic stroke: A systematic review and meta-analysis. Neurology 2020; 94:e75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferro JM, Canhão P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35:664.
          </a>
         </li>
         <li class="breakAll">
          Lamy C, Mas J-L. Hypertensive encephalopathy. In: Stroke: pathophysiology, diagnosis, and management, Mohr JP, Choi DW, Grotta JC, et al. (Eds), Churchill Livingstone, Philadelphia 2004. p.641.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 1999; 14:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reigel MM, Hollier LH, Sundt TM Jr, et al. Cerebral hyperperfusion syndrome: a cause of neurologic dysfunction after carotid endarterectomy. J Vasc Surg 1987; 5:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel UK, Patel K, Malik P, et al. Stroke-like migraine attacks after radiation therapy (SMART) syndrome-a case series and review. Neurol Sci 2020; 41:3123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruyn GW. Intracranial arteriovenous malformation and migraine. Cephalalgia 1984; 4:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monteiro JM, Rosas MJ, Correia AP, Vaz AR. Migraine and intracranial vascular malformations. Headache 1993; 33:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kraemer M, Lee SI, Ayzenberg I, et al. Headache in Caucasian patients with Moyamoya angiopathy - a systematic cohort study. Cephalalgia 2017; 37:496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lopez JI, Holdridge A, Chalela J. Headache and vasculitis. Curr Pain Headache Rep 2013; 17:320.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Younger DS. Headaches and vasculitis. Neurol Clin 2014; 32:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beuker C, Strunk D, Rawal R, et al. Primary Angiitis of the CNS: A Systematic Review and Meta-analysis. Neurol Neuroimmunol Neuroinflamm 2021; 8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salvarani C, Brown RD Jr, Calamia KT, et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007; 62:442.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998; 44:731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan RY, Markus HS. CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships. PLoS One 2016; 11:e0157613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haas DC. Arteriovenous malformations and migraine: case reports and an analysis of the relationship. Headache 1991; 31:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sacco S, Ornello R, Ripa P, et al. Migraine and hemorrhagic stroke: a meta-analysis. Stroke 2013; 44:3032.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. JAMA 2009; 301:2563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bashir A, Lipton RB, Ashina S, Ashina M. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology 2013; 81:1260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurth T, Tzourio C. Migraine and cerebral infarct-like lesions on MRI: an observation, not a disease. JAMA 2009; 301:2594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Brain stem and cerebellar hyperintense lesions in migraine. Stroke 2006; 37:1109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamedani AG, Rose KM, Peterlin BL, et al. Migraine and white matter hyperintensities: the ARIC MRI study. Neurology 2013; 81:1308.
          </a>
         </li>
         <li class="breakAll">
          Medical eligibility for contraceptive use, 5th ed, World Health Organization, Geneva 2015 https://www.who.int/publications/i/item/9789241549158 (Accessed on April 05, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep 2016; 65:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions: Correction. Obstet Gynecol 2019; 133:1288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sacco S, Merki-Feld GS, Ægidius KL, et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain 2017; 18:108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG, et al. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 2006; 67:1128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Main ML, Ramaswamy K, Andrews TC. Cardiac arrest and myocardial infarction immediately after sumatriptan injection. Ann Intern Med 1998; 128:874.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kato Y, Hayashi T, Mizuno S, et al. Triptan-induced Reversible Cerebral Vasoconstriction Syndrome: Two Case Reports with a Literature Review. Intern Med 2016; 55:3525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jayamaha JE, Street MK. Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan. Intensive Care Med 1995; 21:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vijayan N, Peacock JH. Spinal cord infarction during use of zolmitriptan: a case report. Headache 2000; 40:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aboul Nour H, Miller DJ, Danoun OA. Naratriptan-Associated Spinal Artery Infarction. Am J Ther 2021; 28:e734.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kang DO, An H, Park GU, et al. Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction. J Am Coll Cardiol 2020; 76:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chua AL, Mehla S, Orlova YY. Drug Safety in Episodic Migraine Management in Adults. Part 2: Preventive Treatments. Curr Pain Headache Rep 2022; 26:493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orlova YY, Mehla S, Chua AL. Drug Safety in Episodic Migraine Management in Adults Part 1: Acute Treatments. Curr Pain Headache Rep 2022; 26:481.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3344 Version 45.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7711619" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Case-control study of migraine and risk of ischaemic stroke in young women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9872876" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9872876" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1172861" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Oral contraceptives and stroke in young women. Associated risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33368551" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Migraine and Cryptogenic Ischemic Stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32689612" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Prevalence of ischemic stroke and atrial fibrillation in young patients with migraine national inpatient sample analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37310926" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Migraine and risk of premature myocardial infarction and stroke among men and women: A Danish population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27785579" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Migraine and the risk of stroke: an updated meta-analysis of prospective cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10023131" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Migraine history and migraine-induced stroke in the Dijon stroke registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3772405" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Stroke and migraine in the Oxfordshire Community Stroke Project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27118220" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Migraine and incidence of ischemic stroke: A nationwide population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19861375" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Migraine and cardiovascular disease: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12780770" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Migrainous cerebral infarction in the Sagrat Cor Hospital of Barcelona stroke registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27283278" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The Migraine-Stroke Connection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11723268" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Ischemic stroke and active migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11445642" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Headache characteristics in patients after migrainous stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32217787" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Migraine and risk of stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35985832" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Vascular Risk Score and Associations With Past, Current, or Future Migraine in Women: Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20493462" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Migraine headache and ischemic stroke risk: an updated meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22172624" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Migraine and stroke: a complex association with clinical implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29593023" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32515815" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28073753" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Migraine and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21126968" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Migraine and functional outcome from ischemic cerebral events in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22996957" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Migraine and stroke: perspectives for stroke physicians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29386181" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23432441" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Contributions of epidemiology to our understanding of migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22693997" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Thrombotic stroke and myocardial infarction with hormonal contraception.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28034652" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19553594" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Migraine frequency and risk of cardiovascular disease in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17690308" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34997286" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Myocardial infarction, stroke and cardiovascular mortality among migraine patients: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27153744" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Safety of hormonal contraceptives among women with migraine: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29139115" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Risk of Stroke Associated With Use of Estrogen Containing Contraceptives in Women With Migraine: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10872016" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Ischemic stroke risk with oral contraceptives: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15637351" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Migraine and ischaemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22144569" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25228681" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Migraine and stroke: in search of shared mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11359360" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : New neural theory of migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2181979" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Migraine-related stroke in the context of the International Headache Society classification of head pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3549756" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : The association between migraine and cerebral vascular events: an analytical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7969360" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8453456" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3337678" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Migrainous stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2475821" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Serotonin metabolism in migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8178628" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Endothelin 1 in migraine and tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11279903" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Frequency of factor V Leiden in juvenile migraine with aura.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11422096" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Evidence for activation of the coagulation system in migraine with aura.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11468324" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Increased von Willebrand factor in migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15911785" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Migraine as an inflammatory disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19689607" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Migraine as a systemic vasculopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8201323" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Platelet secretion from dense and alpha-granules in vitro in migraine with or without aura.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1132988" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : "Complicated migraine" its association with increased platelet aggregability and abnormal plasma coagulation factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15201354" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22110165" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Migraine and hypercoagulable states in ischemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16365871" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Migraine and MTHFR C677T genotype in a population-based sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11839842" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Migraine and autonomic nervous system function: a population-based, case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12940807" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Electrocardiographic changes during migraine attacks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17502551" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17452542" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Migraine and risk of cardiovascular disease in men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20147658" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Migraine and cardiovascular disease: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27247281" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Migraine and risk of cardiovascular disease in women: prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16006538" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9823834" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28181217" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Hypercoagulability and Migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21511950" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19539236" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Cadasil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28762753" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Migraine in mitochondrial disorders: Prevalence and characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7851451" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Migrainous stroke and the antiphospholipid antibodies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3111715" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Migraine and the lupus anticoagulant. Case reports and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14714915" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Headache and systemic lupus erythematosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12799962" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : [Antinuclear and anticardiolipin antibodies in primary headache syndromes].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12010382" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Migraine is associated with livedo reticularis: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12047335" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Livedo reticularis and migraine: a marker for stroke risk?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6652469" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome). Clinical, radiological and pathological features in eight cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1815538" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Sneddon syndrome presenting with hemicranic attacks: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16686906" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Migraine-mimicking headache and sickle cell disease: a transcranial Doppler study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21624990" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Clinical and MRI characteristics of acute migrainous infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8824003" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Migraine stroke: a possible complication of both migraine with and without aura.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8255442" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Migraine and migrainous stroke: risk factors and prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10573468" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Ischemic stroke and migraine in childhood: coincidence or causal relation?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9277034" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Migraine-related stroke versus migraine-induced stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29368949" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33078475" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Association between Migraine and Cryptogenic Ischemic Stroke in Young Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29661036" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : When migraine mimics stroke: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7388704" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3762963" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Headache in acute cerebrovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14984225" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Sentinel headaches in aneurysmal subarachnoid haemorrhage: what is the true incidence? A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1423556" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Headache in ischemic cerebrovascular disease. Part I: Clinical features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27534709" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Role of atherosclerosis, clot extent, and penumbra volume in headache during ischemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1473132" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Headache in ischemic cerebrovascular disease. Part II: Mechanisms and predictive value.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2067637" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Scintillating scotomata associated with internal carotid artery dissection: report of three cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9746299" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Transient migraine-like symptoms with internal carotid artery dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7644051" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Headache and neck pain in spontaneous internal carotid and vertebral artery dissections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7085262" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : The headache and pain of spontaneous carotid dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28006971" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Association of clinical headache features with stroke location: An MRI voxel-based symptom lesion mapping study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26603369" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Headache in acute ischaemic stroke: a lesion mapping study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33992180" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Headache features of cerebellar ischemic strokes: Clinical and radiological-experiences of a single center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7635716" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : A multivariate study of headache associated with ischemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18479417" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Association between migraine and headache attributed to stroke: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31694924" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Headache after ischemic stroke: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14976332" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14976332" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8559202" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : A reversible posterior leukoencephalopathy syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10342593" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3560356" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Cerebral hyperperfusion syndrome: a cause of neurologic dysfunction after carotid endarterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32661884" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Stroke-like migraine attacks after radiation therapy (SMART) syndrome-a case series and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6498934" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Intracranial arteriovenous malformation and migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8294196" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Migraine and intracranial vascular malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27112705" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Headache in Caucasian patients with Moyamoya angiopathy - a systematic cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23338772" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Headache and vasculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24703534" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Headaches and vasculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34663675" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Primary Angiitis of the CNS: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17924545" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Primary central nervous system vasculitis: analysis of 101 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9818928" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : The phenotypic spectrum of CADASIL: clinical findings in 102 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27309730" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1960053" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Arteriovenous malformations and migraine: case reports and an analysis of the relationship.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24085027" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Migraine and hemorrhagic stroke: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14747499" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Migraine as a risk factor for subclinical brain lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19549973" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Migraine headache in middle age and late-life brain infarcts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23986301" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Migraine and structural changes in the brain: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19549979" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Migraine and cerebral infarct-like lesions on MRI: an observation, not a disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16497982" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Brain stem and cerebellar hyperintense lesions in migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23975874" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Migraine and white matter hyperintensities: the ARIC MRI study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23975874" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Migraine and white matter hyperintensities: the ARIC MRI study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27467196" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31135757" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions: Correction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29086160" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17030745" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Risk of ischemic complications related to the intensity of triptan and ergotamine use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9599209" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Cardiac arrest and myocardial infarction immediately after sumatriptan injection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27904122" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Triptan-induced Reversible Cerebral Vasoconstriction Syndrome: Two Case Reports with a Literature Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7560482" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10759907" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Spinal cord infarction during use of zolmitriptan: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33491969" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Naratriptan-Associated Spinal Artery Infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32731930" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35587859" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Drug Safety in Episodic Migraine Management in Adults. Part 2: Preventive Treatments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35536501" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Drug Safety in Episodic Migraine Management in Adults Part 1: Acute Treatments.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
